Opportunity ID: 54796

General Information

Document Type: Grants Notice
Funding Opportunity Number: APS-OAA-10-000003
Funding Opportunity Title: APS for Biomedical Research for Reproductive Health
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 9
Assistance Listings:
Cost Sharing or Matching Requirement: Yes
Version: Synopsis 5
Posted Date: May 25, 2010
Last Updated Date: Feb 11, 2011
Original Closing Date for Applications: May 24, 2011
Current Closing Date for Applications: May 24, 2011
Archive Date:
Estimated Total Program Funding:
Award Ceiling: $28,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: U.S. Organizations or non-U.S., non-Governement Organizations (NGOs)

Additional Information

Agency Name: Agency for International Development
Description: The purpose of the APS is to publicize this United States Government’s (USG) plan to fund a limited number of awards through USAID/Washington’s Office of Population and Reproductive Health (PRH), and Office of HIV/AIDS (OHA), to address a focused set of family planning/reproductive health (FP/RH) issues. The areas of interest for the APS are listed below. Funds may support the research and development (R&D), regulatory approval, and introduction of new contraceptives that fill existing gaps in the FP method mix, and multipurpose prevention technologies (MPTs) that meet various RH needs of women in low resource settings. The innovative and potentially varied nature of these activities and products, which are united by a theme but not necessarily a common technological platform or programmatic focus, may require a diversity of partners with differing areas of expertise. Thus, the intention of the APS is to marshal the greatest amount of technical expertise for promising product leads and initiatives, while remaining flexible enough to support innovation and respond to the most pressing needs of the field.The objective of the APS is to foster the R&D, regulatory approval, and introduction of:1. New contraceptive methods that fill specific gaps in the existing method mix; 2. MPTs that are contraceptive, and: a. Provide protection from HIV, other sexually transmitted infections (STIs), and/or reproductive tract infections (RTIs);b. Are appropriate for occasional or intermittent use; andc. Provide additional health benefits.The specific aims are discussed in more detail in the Program Description.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alisa Dunn

Agreement Officer

Email:adunn@usaid.gov

Version History

Version Modification Description Updated Date
Amendment No. 1:

Both the scope and timeframe for the second round of concept papers has been modified. The scope will be for concept papers focused on AIM 2 ONLY, and the due date for Round 2 has been extended to May 1, 2011, 3:00pm Eastern Standard Time.

The new point of contact for this APS is Ms. Alisa Dunn, who can be reached at adunn@usaid.gov. Please submit any questions regarding this APS modification, electronically to Ms. Dunn by April 4, 2011, 3:00pm Eastern Standard Time.

Feb 11, 2011
Feb 11, 2011
Jun 10, 2010
Jun 10, 2010
Jun 10, 2010

DISPLAYING: Synopsis 5

General Information

Document Type: Grants Notice
Funding Opportunity Number: APS-OAA-10-000003
Funding Opportunity Title: APS for Biomedical Research for Reproductive Health
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 9
Assistance Listings:
Cost Sharing or Matching Requirement: Yes
Version: Synopsis 5
Posted Date: May 25, 2010
Last Updated Date: Feb 11, 2011
Original Closing Date for Applications: May 24, 2011
Current Closing Date for Applications: May 24, 2011
Archive Date:
Estimated Total Program Funding:
Award Ceiling: $28,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: U.S. Organizations or non-U.S., non-Governement Organizations (NGOs)

Additional Information

Agency Name: Agency for International Development
Description: The purpose of the APS is to publicize this United States Government’s (USG) plan to fund a limited number of awards through USAID/Washington’s Office of Population and Reproductive Health (PRH), and Office of HIV/AIDS (OHA), to address a focused set of family planning/reproductive health (FP/RH) issues. The areas of interest for the APS are listed below. Funds may support the research and development (R&D), regulatory approval, and introduction of new contraceptives that fill existing gaps in the FP method mix, and multipurpose prevention technologies (MPTs) that meet various RH needs of women in low resource settings. The innovative and potentially varied nature of these activities and products, which are united by a theme but not necessarily a common technological platform or programmatic focus, may require a diversity of partners with differing areas of expertise. Thus, the intention of the APS is to marshal the greatest amount of technical expertise for promising product leads and initiatives, while remaining flexible enough to support innovation and respond to the most pressing needs of the field.The objective of the APS is to foster the R&D, regulatory approval, and introduction of:1. New contraceptive methods that fill specific gaps in the existing method mix; 2. MPTs that are contraceptive, and: a. Provide protection from HIV, other sexually transmitted infections (STIs), and/or reproductive tract infections (RTIs);b. Are appropriate for occasional or intermittent use; andc. Provide additional health benefits.The specific aims are discussed in more detail in the Program Description.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Alisa Dunn

Agreement Officer

Email:adunn@usaid.gov

DISPLAYING: Synopsis 4

General Information

Document Type: Grants Notice
Funding Opportunity Number: APS-OAA-10-000003
Funding Opportunity Title: APS for Biomedical Research for Reproductive Health
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 9
Assistance Listings:
Cost Sharing or Matching Requirement: Yes
Version: Synopsis 4
Posted Date: Feb 11, 2011
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 24, 2011
Archive Date:
Estimated Total Program Funding:
Award Ceiling: $28,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: U.S. Organizations or non-U.S., non-Governement Organizations (NGOs)

Additional Information

Agency Name: Agency for International Development
Description: The purpose of the APS is to publicize this United States Government’s (USG) plan to fund a limited number of awards through USAID/Washington’s Office of Population and Reproductive Health (PRH), and Office of HIV/AIDS (OHA), to address a focused set of family planning/reproductive health (FP/RH) issues. The areas of interest for the APS are listed below. Funds may support the research and development (R&D), regulatory approval, and introduction of new contraceptives that fill existing gaps in the FP method mix, and multipurpose prevention technologies (MPTs) that meet various RH needs of women in low resource settings. The innovative and potentially varied nature of these activities and products, which are united by a theme but not necessarily a common technological platform or programmatic focus, may require a diversity of partners with differing areas of expertise. Thus, the intention of the APS is to marshal the greatest amount of technical expertise for promising product leads and initiatives, while remaining flexible enough to support innovation and respond to the most pressing needs of the field.The objective of the APS is to foster the R&D, regulatory approval, and introduction of:1. New contraceptive methods that fill specific gaps in the existing method mix; 2. MPTs that are contraceptive, and: a. Provide protection from HIV, other sexually transmitted infections (STIs), and/or reproductive tract infections (RTIs);b. Are appropriate for occasional or intermittent use; andc. Provide additional health benefits.The specific aims are discussed in more detail in the Program Description.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Ebony Fultz

Contract Specialist

Phone 202-712-5473
Email:efultz@usaid.gov

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: APS-OAA-10-000003
Funding Opportunity Title: APS for Biomedical Research for Reproductive Health
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 9
Assistance Listings: []
Cost Sharing or Matching Requirement: Yes
Version: Synopsis 3
Posted Date: Jun 10, 2010
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 24, 2011
Archive Date:
Estimated Total Program Funding:
Award Ceiling: $28,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: U.S. Organizations or non-U.S., non-Governement Organizations (NGOs)

Additional Information

Agency Name:
Description: The purpose of the APS is to publicize this United States Government’s (USG) plan to fund a limited number of awards through USAID/Washington’s Office of Population and Reproductive Health (PRH), and Office of HIV/AIDS (OHA), to address a focused set of family planning/reproductive health (FP/RH) issues. The areas of interest for the APS are listed below. Funds may support the research and development (R&D), regulatory approval, and introduction of new contraceptives that fill existing gaps in the FP method mix, and multipurpose prevention technologies (MPTs) that meet various RH needs of women in low resource settings. The innovative and potentially varied nature of these activities and products, which are united by a theme but not necessarily a common technological platform or programmatic focus, may require a diversity of partners with differing areas of expertise. Thus, the intention of the APS is to marshal the greatest amount of technical expertise for promising product leads and initiatives, while remaining flexible enough to support innovation and respond to the most pressing needs of the field.The objective of the APS is to foster the R&D, regulatory approval, and introduction of:1. New contraceptive methods that fill specific gaps in the existing method mix; 2. MPTs that are contraceptive, and: a. Provide protection from HIV, other sexually transmitted infections (STIs), and/or reproductive tract infections (RTIs);b. Are appropriate for occasional or intermittent use; andc. Provide additional health benefits.The specific aims are discussed in more detail in the Program Description.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Ebony Fultz

Contract Specialist

Phone 202-712-5473
Email:efultz@usaid.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: APS-OAA-10-000003
Funding Opportunity Title: APS for Biomedical Research for Reproductive Health
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 9
Assistance Listings: []
Cost Sharing or Matching Requirement: Yes
Version: Synopsis 2
Posted Date: Jun 10, 2010
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 24, 2011
Archive Date:
Estimated Total Program Funding:
Award Ceiling: $28,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: U.S. Organizations or non-U.S., non-Governement Organizations (NGOs)

Additional Information

Agency Name:
Description: The purpose of the APS is to publicize this United States Government’s (USG) plan to fund a limited number of awards through USAID/Washington’s Office of Population and Reproductive Health (PRH), and Office of HIV/AIDS (OHA), to address a focused set of family planning/reproductive health (FP/RH) issues. The areas of interest for the APS are listed below. Funds may support the research and development (R&D), regulatory approval, and introduction of new contraceptives that fill existing gaps in the FP method mix, and multipurpose prevention technologies (MPTs) that meet various RH needs of women in low resource settings. The innovative and potentially varied nature of these activities and products, which are united by a theme but not necessarily a common technological platform or programmatic focus, may require a diversity of partners with differing areas of expertise. Thus, the intention of the APS is to marshal the greatest amount of technical expertise for promising product leads and initiatives, while remaining flexible enough to support innovation and respond to the most pressing needs of the field.The objective of the APS is to foster the R&D, regulatory approval, and introduction of:1. New contraceptive methods that fill specific gaps in the existing method mix; 2. MPTs that are contraceptive, and: a. Provide protection from HIV, other sexually transmitted infections (STIs), and/or reproductive tract infections (RTIs);b. Are appropriate for occasional or intermittent use; andc. Provide additional health benefits.The specific aims are discussed in more detail in the Program Description.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Ebony Fultz

Contract Specialist

Phone 202-712-5473
Email:efultz@usaid.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: APS-OAA-10-000003
Funding Opportunity Title: APS for Biomedical Research for Reproductive Health
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 9
Assistance Listings: []
Cost Sharing or Matching Requirement: Yes
Version: Synopsis 1
Posted Date: Jun 10, 2010
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 24, 2011
Archive Date:
Estimated Total Program Funding:
Award Ceiling: $13,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: U.S. Organizations or non-U.S., non-Governement Organizations (NGOs)

Additional Information

Agency Name: Agency for International Development
Description: The purpose of the APS is to publicize this United States Government’s (USG) plan to fund a limited number of awards through USAID/Washington’s Office of Population and Reproductive Health (PRH), and Office of HIV/AIDS (OHA), to address a focused set of family planning/reproductive health (FP/RH) issues. The areas of interest for the APS are listed below. Funds may support the research and development (R&D), regulatory approval, and introduction of new contraceptives that fill existing gaps in the FP method mix, and multipurpose prevention technologies (MPTs) that meet various RH needs of women in low resource settings. The innovative and potentially varied nature of these activities and products, which are united by a theme but not necessarily a common technological platform or programmatic focus, may require a diversity of partners with differing areas of expertise. Thus, the intention of the APS is to marshal the greatest amount of technical expertise for promising product leads and initiatives, while remaining flexible enough to support innovation and respond to the most pressing needs of the field.

The objective of the APS is to foster the R&D, regulatory approval, and introduction of:
1. New contraceptive methods that fill specific gaps in the existing method mix;
2. MPTs that are contraceptive, and:
a. Provide protection from HIV, other sexually transmitted infections (STIs), and/or reproductive tract infections (RTIs);
b. Are appropriate for occasional or intermittent use; and
c. Provide additional health benefits.
The specific aims are discussed in more detail in the Program Description.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Ebony Fultz

Contract Specialist

Phone 202-712-5473
Email:efultz@usaid.gov

Folder 54796 Full Announcement-1 -> apsbiomedialresearchforreproductivehealth.pdf

Folder 54796 Other Supporting Documents-Amendment No. 01 Letter and Questions and Answers 1 -> amendment no. 01 biomedical research aps.pdf

Folder 54796 Other Supporting Documents-Amendment No. 01 Letter and Questions and Answers 1 -> biomedical research questions with answers.pdf

Packages

Agency Contact Information: Alisa Dunn
Agreement Officer

Email: adunn@usaid.gov

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
PKG00020034 May 25, 2010 May 24, 2011 View

Package 1

Mandatory forms

54796 SF424_2_1-2.1.pdf

54796 SF424D-1.1.pdf

54796 SF424C-1.0.pdf

54796 SF424B-1.1.pdf

54796 SF424A-1.0.pdf

Optional forms

54796 FaithBased_SurveyOnEEO-1.2.pdf

2025-07-11T14:02:08-05:00

Share This Post, Choose Your Platform!

About the Author: